5/15/09 update
The Bulls took a little snooze last week and the Nasdaq Composite Index closed Friday up 6.91% CYTD, or Contest Year To Date, (vs. up 10.65% CYTD a week ago). The Nasdaq Biotech Index held up a bit better, closing the week down -5.85% CYTD (vs. down -5.12% CYTD a week ago) while the Contest median gave back most of the prior week's gains, closing down -4.45% CYTD (vs. down -.45% CYTD a week ago).
With the help of TKM.TO, GENE's portfolio took back first place with GEORGIA's portfolio slipping back into second and RKRW's portfolio remaining in the No. 3 position. The end of the week CYTD percentages are: GENE up 54.76%, GEORGIA up 44.37% and RKRW up 43.13%.
At Friday's close, 14 of the 32 Contest portfolios are in the black and 18 of the 32 are beating the NBI.
Enjoy the weekend biotechies!
Below is the Top Ten list on 5/15/09:
5/15/09
Rank Name Profit/Loss
1 GENE 54,758
2 GEORGIA 44,374
3 RKRW 43,129
4 PRAVN 35,755
5 BULBA 34,243
6 ENZYME 24,484
7 WILDER 21,195
8 MIKE 16,161
9 ASHLEY 15,010
10 SCARAM 8,854
(All corrections, especially adjustments for splits, greatly appreciated.) |
